Revolutionizing CAR-T Therapy Production with a New Cytokine Solution
In a significant breakthrough for cell and gene-modified therapies, ScaleReady and Bio-Techne Corporation (NASDAQ: TECH) have unveiled the G-Rex optimized ProPak GMP Cytokines. This cutting-edge product is tailored for high-efficiency closed system manufacturing, reshaping the production landscape for CAR-T and TCR therapies.
The ProPak GMP Cytokines come in a ready-to-use, weldable bag filled with liquid GMP-grade cytokines. Key components include interleukin-7 (IL-7) and interleukin-15 (IL-15), both vital for the ex vivo culture of CAR-T and TCR-T cells. Each ProPak is expertly formulated to deliver the correct dosage of cytokines for a one-liter G-Rex bioreactor, ensuring a precise concentration of 10ng/mL. This innovation significantly reduces the operational complexities associated with therapy production.
Advantages of ProPak GMP Cytokines
The launch of ProPak GMP Cytokines marks a leap forward in how manufacturers manage essential reagents in cell therapy production. By utilizing these cytokines, companies can dramatically lower costs and streamline their processes. The new packaging eliminates cumbersome steps related to sourcing, storing, and preparing cytokines, facilitating a more efficient manufacturing workflow while adhering to cGMP standards.
Insights from Experts on the New Product
Will Geist, President of Protein Sciences at Bio-Techne Corporation, emphasizes the company's commitment to improving the production of life-saving therapies. He pointed out that ProPak Cytokines are specifically crafted to work seamlessly with the leading G-Rex platform, ultimately enhancing outcomes in cell-based drug production.
In a similar vein, Josh Ludwig, the Global Commercial Director at ScaleReady, highlighted that this product truly stands out by simplifying the manufacturing process. Users can create CAR-T and TCR-T therapies without the hassle of reconstituting cytokines, opting instead for a straightforward method that takes full advantage of the G-Rex manufacturing system.
Widespread Acceptance and Support
This innovative approach is pivotal in the G-Rex Grant Program, aimed at encouraging the use of the G-Rex platform in clinical studies. Many organizations are already incorporating the G-Rex system, and with the ProPak GMP Cytokines now available, productivity is set to increase even further. Ludwig reassured that all G-Rex users, regardless of grant applications, can effectively utilize the ProPak for their studies on comparability.
About ScaleReady
ScaleReady is committed to offering the cell and gene-modified cell therapy industry a G-Rex centric manufacturing platform. This dedication supports the development and production of CGT products that are not just scalable but also cost-effective. Firms leveraging ScaleReady's extensive expertise can expect to significantly reduce timelines and financial pressures associated with entering the CGT market.
Employing the G-Rex Manufacturing Platform
The G-Rex platform is already in use for half of all clinical trials and supports more than 800 organizations engaged in CGT drug production. Its flexibility and reliability have facilitated the commercial approval of four CGT drugs, highlighting its effectiveness in both autologous and allogeneic therapies. The outlook is bright as ScaleReady continues to expand its influence within the CGT sector.
About Bio-Techne Corporation
Bio-Techne Corporation (NASDAQ: TECH) stands as a leader in the life sciences field, providing innovative tools and bioactive reagents that support both research and clinical diagnostics. The company collaborates with Wilson Wolf to create specialized media and cytokines that are perfectly suited for G-Rex Bioreactors, ensuring optimal effectiveness in high-throughput manufacturing.
Frequently Asked Questions
What are ProPak GMP Cytokines?
ProPak GMP Cytokines are a new product designed to facilitate closed system manufacturing of CAR-T and TCR therapies. They come in a ready-to-use format and include GMP-grade cytokines.
How do ProPak GMP Cytokines benefit therapy production?
The ProPak simplifies cytokine acquisition and handling, helping to lower operational costs while ensuring compliance with manufacturing regulations.
What cytokines are included in the ProPak?
Each ProPak contains interleukin-7 (IL-7) and interleukin-15 (IL-15), which are crucial for the effective culture of CAR-T and TCR-T cells.
Can users of G-Rex access the ProPak Cytokines?
Yes, G-Rex users, including those who do not apply for grants, can use ProPak GMP Cytokines for their compatibility studies and production needs.
What is the G-Rex Grant Program?
The G-Rex Grant Program supports organizations using the G-Rex platform, aiding them in incorporating new technologies like ProPak GMP Cytokines into their operations.
